FDA Officially Belongs to Big Pharma With Senate Confirmation of Dr. Robert Califf
It is hard to believe only four senators opposed the confirmation of Robert Califf, who was approved Wednesday as the next Food and Drug Administration (FDA) commissioner. Vocal opponent Bernie Sanders condemned the vote from the campaign trail. But where was Dick Durbin? Where were all the lawmakers who say they care about industry and Wall Street profiteers making money at the expense of public health?
Califf, chancellor of clinical and translational research at Duke University until recently, received money from 23 drug companies including the giants like Johnson & Johnson, Lilly, Merck, Schering Plough and GSK according to a disclosure statement on the website of Duke Clinical Research Institute.
Not merely receiving research funds, Califf also served as a high level Pharma officer, say press reports. Medscape, the medical website, discloses that Califf “served as a director, officer, partner, employee, advisor, consultant or trustee for Genentech.” Portola Pharmaceuticals says Califf served on its board of directors until leaving for the FDA.
In disclosure information for a 2013 article in Circulation, Califf also lists financial links to Gambro, Regeneron, Gilead, AstraZeneca, Roche and other companies and equity positions in four medical companies. Gilead is the maker of the $1000-a-pill hepatitis C drug AlterNet recently wrote about. This is FDA commissioner material?
Califf has gone on record that collaboration between industry and regulators is a good thing. He told NPR, “Many of us consult with the pharmaceutical industry, which I think is a very good thing. They need ideas and then the decision about what they do is really up to the person who is funding the study.” What?
He is known for defending Vioxx which is reported to have caused at least 50,000 heart attacks and events before its withdrawal. (Merck is said to have known about Vioxx’ cardio effects but marketed the blockbuster drug anyway).
Califf was instrumental in the Duke drug trial of the blood thinner Xarelto and a cheerleader of the drug despite medical experts’ objections to its approval and 379 subsequent deaths. Xarelto's serious and foreseeable risks were back in the news this week.
Duke, where Califf directed clinical research, is still recovering from a major research fraud scandal that resulted in terminated grants, retracted papers and a "60 Minutes" special. It is the least appropriate place from which to choose an FDA commissioner.
Many had high hopes for the FDA when Margaret Hamburg was confirmed as commissioner in 2009 because of her public health background. But she swiftly moved to loosen conflict-of-interest rules governing those who can serve on FDA expert advisory committees and appointed Califf the FDA deputy commissioner for medical products and tobacco as she was leaving.
Califf was also Obama's choice for FDA Commissioner.
This is not the first time the FDA has brought in a Big Pharma cheerleader to lead the agency that regulates Big Pharma.
In 2005, a 33-year-old Wall Street insider known for recommending hot medical stocks, Scott Gottlieb, was named FDA deputy commissioner for medical and scientific affairs. When a multiple sclerosis drug trial was stopped because three people lost blood platelets and one died, Gottlieb called it "an overreaction" because the disease, not the drug, might be to blame. He rushed Chantix, Pfizer’s stop-smoking drug, varenicline, to market, which was linked to a string of 2006 suicides and the violent death of Dallas musician Carter Albrecht. Gottlieb was forced to recuse himself from planning for a possible bird flu epidemic because of his financial ties to Roche and Sanofi-Aventis and had to bow out of work related to Eli Lilly, Proctor & Gamble and five other drug companies.
Even without a Pharma-funded FDA commissioner, many dangerous drugs approved by the agency have been withdrawn due to great harm. Who remembers Vioxx, Bextra, Baycol, Trovan, Meridia, Seldane, Hismanal, Darvon, Mylotarg, Lotronex, Propulsid, Raxar or Redux?
Califf's confirmation amounts to a handover of the agency to Big Pharma.
YOU MIGHT ALSO LIKE
By Jake Johnson
Amid reports that oil industry-friendly former Energy Secretary Ernest Moniz remains under consideration to return to his old post in the incoming Biden administration, a diverse coalition of environmental groups is mobilizing for an "all-out push" to keep Moniz away from the White House and demand a cabinet willing to boldly confront the corporations responsible for the climate emergency.
EcoWatch Daily Newsletter
Anger, anxiety, overwhelm … climate change can evoke intense feelings.
"It's easy to feel dwarfed in the context of such a global systemic issue," says psychologist Renée Lertzman.
She says that when people experience these feelings, they often shut down and push information away. So to encourage climate action, she advises not bombarding people with frightening facts.
"When we lead with information, we are actually unwittingly walking right into a situation that is set up to undermine our efforts," she says.
She says if you want to engage people on the topic, take a compassionate approach. Ask people what they know and want to learn. Then have a conversation.
This conversational approach may seem at odds with the urgency of the issue, but Lertzman says it can get results faster.
"When we take a compassion-based approach, we are actively disarming defenses so that people are actually more willing and able to respond and engage quicker," she says. "And we don't have time right now to mess around, and so I do actually come to this topic with a sense of urgency… We do not have time to not take this approach."
Reporting credit: ChavoBart Digital Media
Reposted with permission from Yale Climate Connections.
- Your Guide to Talking With Kids of All Ages About Climate Change ... ›
- 7 of the Best Ted Talks About Climate Change - EcoWatch ›
- Katharine Hayhoe Reveals Surprising Ways to Talk About Climate ... ›
An extremely rare North Atlantic right whale calf was found dead off the North Carolina coast on Friday.
<div class="rm-shortcode" data-rm-shortcode-id="24c36ab7f041f96875677ba1e9dc1944"><div class="fb-post" data-href="https://www.facebook.com/CapeLookoutNPS/posts/3608024915884969"></div></div>
- 411 North Atlantic Right Whales Remain: This Solution Could Help ... ›
- Sixth North Atlantic Right Whale Found Dead Prompts Concern ... ›
- First North Atlantic Right Whale Calf of the Season Spotted off ... ›
By Andrea Germanos
A new report released Tuesday details the "shocking" state of global land equality, saying the problem is worse than thought, rising, and "cannot be ignored."
- We Need a Green New Deal for Farmland - EcoWatch ›
- The Netherlands Can Feed the World. Here's Why It Shouldn't ... ›
- The Key to Saving Family Farms Is in the Soil - EcoWatch ›
- Urban Farming Booms During Coronavirus Lockdowns - EcoWatch ›
In yet another attack on the environment before leaving office, the Trump administration is seeking to transfer ownership of San Carlos Apache holy ground in Oak Flat, Arizona, to a copper mining company.
- Mining Giant BHP Pauses Plans to Blast 40 Aboriginal Heritage Sites ›
- Mining Company CEO Forced to Resign After Blasting of 46,000 ... ›
- Rio Tinto Blasted Away an Ancient Aboriginal Site. Here's Why That ... ›